Alex Pearson
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
-
- Fibroblast Growth Factor Research 9
- Wnt/β-catenin signaling in development and cancer 2
- Genetics 7
- Estrogen and related hormone effects 3
- Genomic variations and chromosomal abnormalities 3
- Co-authors
- Nicholas C. Turner (17 shared papers)Rachel Sharpe (6 shared papers)Rachael Natrajan (4 shared papers)Alan Ashworth (5 shared papers)Alan Mackay (4 shared papers)Jorge S. Reis‐Filho (4 shared papers)Felipe C. Geyer (3 shared papers)Maryou Lambros (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Annals of Oncology (3 papers)Cancer Research (3 papers)Oncogene (2 papers)Cancer Discovery (2 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Alex Pearson
22 papers receiving 1.3k citations
Alex Pearson's Hit Papers
Peers
Comparison fields: 5 of 87
- Cancer Research 439
- Oncology 530
- Molecular Biology 872
- Pulmonary and Respiratory Medicine 307
- Genetics 160
Countries citing papers authored by Alex Pearson
This map shows the geographic impact of Alex Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Pearson more than expected).
Fields of papers citing papers by Alex Pearson
This network shows the impact of papers produced by Alex Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Pearson. The network helps show where Alex Pearson may publish in the future.
Co-authors
The 25 scholars most cited alongside Alex Pearson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer Hit paper breakdown → | 2010 | 544 |
| 2 | 2010 | 322 | |
| 3 | 2011 | 144 | |
| 4 | 2013 | 98 | |
| 5 | 1994 | 65 | |
| 6 | 2013 | 28 | |
| 7 | 2023 | 21 | |
| 8 | 2015 | 18 | |
| 9 | 1984 | 16 | |
| 10 | 2016 | 15 | |
| 11 | 2019 | 14 | |
| 12 | 2000 | 13 | |
| 13 | 2018 | 12 | |
| 14 | 1983 | 9 | |
| 15 | 2015 | 6 | |
| 16 | 2022 | 5 | |
| 17 | 2021 | 4 | |
| 18 | 2018 | 4 | |
| 19 | 2015 | 2 | |
| 20 | 2010 | 1 |
About Alex Pearson
Alex Pearson is a scholar working on Molecular Biology, Genetics, Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 22 papers that have together received 1.3k indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (9 papers), Cancer Genomics and Diagnostics (3 papers), Advanced Breast Cancer Therapies (3 papers), Estrogen and related hormone effects (3 papers), Genomic variations and chromosomal abnormalities (3 papers), Cancer Treatment and Pharmacology (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Cancer Research (439 citations), Oncology (530 citations), Molecular Biology (872 citations), Pulmonary and Respiratory Medicine (307 citations) and Genetics (160 citations). Alex Pearson has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Nicholas C. Turner, Rachel Sharpe, Rachael Natrajan, Alan Ashworth, Alan Mackay, Jorge S. Reis‐Filho, Felipe C. Geyer, Maryou Lambros, Anita Grigoriadis and Elizabeth Iorns. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Oncogene and Cancer Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.